Charlotte's Web Holdings (CWBHF) Asset Writedowns and Impairment (2021 - 2025)
Charlotte's Web Holdings (CWBHF) posted quarterly Asset Writedowns and Impairment of $312000.0 for Q4 2025, up 36.84% year-over-year from $228000.0 in Q4 2024, and up 402.91% quarter-over-quarter from -$103000.0 in Q3 2025.
Charlotte's Web Holdings (CWBHF) Asset Writedowns and Impairment (2021 - 2025) Analysis & Trends
Charlotte's Web Holdings (CWBHF) has reported Asset Writedowns and Impairment for 5 consecutive years, with $312000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Asset Writedowns and Impairment rose 36.84% year-over-year to $312000.0; the TTM figure through Dec 2025 stood at $437000.0 (up 850.0% YoY), while the FY2025 annual figure was $205000.0, down 95.06% from the prior year.
- Asset Writedowns and Impairment improved to $312000.0 in Q4 2025 per CWBHF's latest filing, from -$103000.0 in the prior quarter.
- Across five years, Asset Writedowns and Impairment topped out at $98.0 million in Q4 2021 and bottomed at -$182000.0 in Q4 2023.
- Historically, Asset Writedowns and Impairment has averaged $10.3 million across 5 years, with a median of $319000.0 in 2023.
- Annual changes were most pronounced in 2022 — Asset Writedowns and Impairment jumped 245.17% — and 2023, when it slumped 100.89%.
- Charlotte's Web Holdings' Asset Writedowns and Impairment stood at $98.0 million in 2021, then plunged by 79.24% to $20.3 million in 2022, then tumbled by 100.89% to -$182000.0 in 2023, then jumped by 225.27% to $228000.0 in 2024, then jumped by 36.84% to $312000.0 in 2025.
- Business Quant data shows CWBHF's Asset Writedowns and Impairment at $312000.0 in Q4 2025, -$103000.0 in Q3 2025, and $228000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Charlotte's Web Holdings | 67.01 Mn | 53.02 Mn | 5.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 312,000.00 |
| Dec 31, 2025 | 312,000.00 |
| Sep 30, 2025 | -103,000.00 |
| Sep 30, 2025 | -103,000.00 |
| Dec 31, 2024 | 228,000.00 |
| Dec 31, 2024 | 228,000.00 |
| Dec 31, 2023 | -182,000.00 |
| Dec 31, 2023 | -182,000.00 |
| Jun 30, 2023 | -6,000.00 |
| Jun 30, 2023 | -6,000.00 |
| Mar 31, 2023 | 326,000.00 |
| Mar 31, 2023 | 326,000.00 |
| Dec 31, 2022 | 20.35 Mn |
| Dec 31, 2022 | 20.35 Mn |
| Sep 30, 2022 | 1.82 Mn |
| Sep 30, 2022 | 1.82 Mn |
| Jun 30, 2022 | 1.86 Mn |
| Jun 30, 2022 | 1.86 Mn |
| Dec 31, 2021 | 98.00 Mn |
| Dec 31, 2021 | 98.00 Mn |